July 30, 2010 (Vienna, Austria) — Although initiation of highly active antiretroviral therapy (HAART) against HIV is associated with a lower risk for progression to AIDS, and a lower risk for ...

HIV viruses infecting T-lymphocytes, computer illustration. The surface of the T-cell has a lumpy appearance with large irregular surface protrusions. Smaller spherical structures on the cell surface ...

Living with HIV means becoming fluent in a language of numbers that might seem confusing at first but actually hold the key to your health and future. Two numbers in particular – your viral load and ...

Our data demonstrates that among patients initiating therapy in RLS with (mainly) an NNRTI-based regimen, CD4 cell count recovery is impaired in the presence of on-going HIV-RNA replication over an 18 ...

National Institutes of Health researchers shared new details about idiopathic CD4 lymphocytopenia (ICL), a rare immune deficiency that leaves people vulnerable to infectious diseases, autoimmune ...

Immunocompromised populations develop a lower immunogenic response to COVID-19 vaccines, leaving them at a higher risk of severe disease, hospitalization, and death. Patients with HIV who have low ...

People with HIV who have moderate immune suppression appear to be at greater risk of severe COVID-19 'breakthrough' infection after vaccination, according to a new study. People with HIV who have ...

A panelist discusses how CD4 counts serve as measures of immune system status that typically increase by about 200 in the first year of antiretroviral therapy. Although there can be laboratory ...

Among treatment-naive adults with advanced HIV disease, integrase inhibitors are a preferred first-line therapy over protease inhibitors.

How Are HIV and Toxoplasmosis Related? To understand how common toxoplasmosis is, you need to know how many people test positive for the T. gondii parasite. About 10% of U.S. adults have the parasite.